Evidence map›Paper›PMID 25003110›Full record

ReviewBioMed research international2014

18F-labeling using click cycloadditions.

Kathrin Kettenbach, Hanno Schieferstein, Tobias L Ross

Abstract readReview
In one paragraph

Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. SyntheticRSC medicinal chemistry · 2024
    Review
  3. Review
  4. Review
  5. Synthesis of the Novel ATACS omega · 2020
    Article
  6. Synthesis and Evaluation of [Molecules (Basel, Switzerland) · 2020
    Article
  7. Article
  8. Preclinical validations of [EJNMMI radiopharmacy and chemistry · 2017
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kathrin KettenbachInstitute of Nuclear Chemistry, Johannes Gutenberg University Mainz, 55128 Mainz, Germany.ORCID 0000-0003-1741-2864
Hanno SchiefersteinInstitute of Nuclear Chemistry, Johannes Gutenberg University Mainz, 55128 Mainz, Germany.ORCID 0000-0001-7286-3380
Tobias L RossInstitute of Nuclear Chemistry, Johannes Gutenberg University Mainz, 55128 Mainz, Germany ; Radiopharmaceutical Chemistry, Department of Nuclear Medicine, Hannover Medical School, 30625 Hannover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to expanding applications of positron emission tomography (PET) there is a demand for developing new techniques to introduce fluorine-18 (t 1/2 = 109.8 min). Considering that most novel PET tracers are sensitive biomolecules and that direct introduction of fluorine-18 often needs harsh conditions, the insertion of (18)F in those molecules poses an exceeding challenge. Two major challenges during (18)F-labeling are a regioselective introduction and a fast and high yielding way under mild conditions. Furthermore, attention has to be paid to functionalities, which are usually present in complex structures of the target molecule. The Cu-catalyzed azide-alkyne cycloaddition (CuAAC) and several copper-free click reactions represent such methods for radiolabeling of sensitive molecules under the above-mentioned criteria. This minireview will provide a quick overview about the development of novel (18)F-labeled prosthetic groups for click cycloadditions and will summarize recent trends in copper-catalyzed and copper-free click (18)F-cycloadditions.

Indexed as

Cycloaddition ReactionStaining and LabelingAnimalsCatalysisClick ChemistryCopperFluorine RadioisotopesCopperFluorine Radioisotopes

Identifiers

PMID25003110
PMCPMC4070495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.